XML 31 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Weighted Average Shares Outstanding
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
WEIGHTED AVERAGE SHARES OUTSTANDING
NOTE I – WEIGHTED AVERAGE SHARES OUTSTANDING

Three Months Ended June 30,Six Months Ended June 30,
(in millions)2025202420252024
Weighted average shares outstanding — basic1,479.9 1,470.6 1,478.5 1,469.5 
Net effect of common stock equivalents13.7 13.6 14.8 13.5 
Weighted average shares outstanding - diluted1,493.5 1,484.2 1,493.3 1,483.0 

The following securities were excluded from the calculation of weighted average shares outstanding - diluted because their effect in the periods presented below would have been antidilutive:
Three Months Ended June 30,Six Months Ended June 30,
(in millions)2025202420252024
Stock options outstanding(1)
1—1—
(1)    Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.
We base Net income (loss) per common share - diluted upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options and stock awards from the calculation if the effect would be anti-dilutive.

We issued approximately one million shares of our common stock in the second quarter of 2025, approximately six million shares in the first six months of 2025, approximately one million shares in the second quarter of 2024 and approximately five million shares in the first six months of 2024. Shares were issued following the exercise of stock options, vesting of restricted stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first six months of 2025 or 2024. On December 14, 2020, our Board of Directors approved a stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of June 30, 2025, we had the full amount remaining available under the authorization.